WASHINGTON (Reuters) - U.S. health regulators said on Friday they have submitted to Congress new recommendations for how manufacturers will help fund their review of new branded drugs, conventional generic medicines and a new generation of generic biotech treatments. At the same time, they have still not finalized how such "user fee" programs will apply to a review of medical devices. Under a user fee program, manufacturers pay to fund part of the Food and Drug Administration's review process, helping speed the decision of whether to bring new drugs to the U.S. market. ... read more..
Antidepressants While Pregnant Linked to Slight Risk of Lung Problem in Babies
THURSDAY, Jan. 12 (HealthDay News) -- Women who use antidepressants called selective serotonin-reuptake inhibitors such as Prozac and Celexa during pregnancy run a slight risk of having an infant with high blood pressure in the lungs, a new Swedish study finds. read more..
No comments:
Post a Comment